Tissue destruction in periodontitis: Bacteria or cytokines fault?

Quintessence International

Volumn 36, Issue 4, 2005, Pages 299-306

  Bascones, Antonio ^a   Noronha, Susana ^b   Gómez, Maria ^a   Mota, P ^b   Gonzalez Moles M A ^c   Villarroel Dorrego, Mariana ^d  

^a UNIVERSIDAD COMPLUTENSE DE MADRID   (Spain)

^b University of Granada ^*

^c UNIVERSITY OF GRANADA   (Spain)

^d Univ S Maria Ctrl de Venezuela   (Spain)

Author keywords

Chemokine; Cytokines; Immunology; Interleukin; Lymphocytes; Periodontitis

Indexed keywords

CHEMOKINE; CYTOKINE; INTERLEUKIN 1; INTERLEUKIN 8; PROSTAGLANDIN E2; TUMOR NECROSIS FACTOR ALPHA;

BONE DESTRUCTION; CELL INTERACTION; ENVIRONMENTAL FACTOR; HOST CELL; HOST RESISTANCE; HUMAN; IMMUNE RESPONSE; LEUKOCYTE; MICROBIAL ACTIVITY; PERIODONTITIS; REVIEW; TISSUE INJURY;

EID: 16244419723     PISSN: 00336572     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (58)

1. Gemmell E, Yamazaki K, Seymour GJ. Destructive periodontitis lesions are determined by the nature of the lymphocytic response. Crit Rev Oral Biol Med 2002;13:17-34.
2. Berglundh T, Liljenberg B, Lindhe J. Some cytokine profiles of T-helper cells in lesions of advanced periodontitis. J Clin Periodontol 2002;29:705-709.
3. Seymour GJ, Gemmell E. Cytokines in periodontal disease: Where to from here? Acta Odontol Scand 2001;59:167-173.
4. Delima AJ, Karatzas S, Amar S, Graves DT. Inflammation and tissue loss caused by periodontal pathogens is reduced by interleukin-1 antagonists. J Infect Dis 2002;186:511-516.
5. Boch JA, Wara-aswapati N, Auron PE. Interleukin 1 signal transduction - Current concepts and relevance to periodontitis. J Dent Res 2001;80:400-407.
6. Weber RL, lacono VJ. The cytokines: A review of interleukins. Periodontal Clin Investig 1997;19:17-22.
7. Matsuki Y, Yamamoto T, Hara K. Interleukin-1 mRNA-expressing macrophages in human chronically inflamed gingival tissues. Am J Pathol 1991;138:1299-1305.
8. Matsuki Y, Yamamoto T, Hara K. Detection of inflammatory cytokine messenger RNA (mRNA)-expressing cells in human inflamed gingiva by combined in situ hybridization and immunohistochemistry. Immunol 1992;76:42-47.
9. Czuszak CA, Sutherland DE, Billman MA, Stein SH. Prostaglandin E2 potentiates interleukin-1 beta induced interleukin-6 production by human gingival fibroblasts. J Clin Periodontol 1996;23:635-640.
10. Brikedal-Hansen H. Role of cytokines and inflammatory mediators in tissue destruction. J Periodontal Res 1993;28:500-510.
11. Ishihara Y, Nishihara T, Kuroyanagi T, et al. Gingival crevicular interleukin-1 and interleukin-1 receptor antagonist levels in periodontally healthy and diseased sites. J Periodontal Res 1997;32:524-529.
12. Rawlinson A, Dalati MH, Rahman S, Walsh TF, Fairclough AL. Interleukin-1 and IL-1 receptor antagonist in gingival crevicular fluid. J Clin Periodontol 2000;27:738-743.
13. Figueredo CMS, Ribeiro MSM, Fischer RG, Gustafsson A. Increased Interleukin-1b concentration in gingival crevicular fluid as a characteristic of periodontitis. J Periodontol 1999;70:1457-1463.
14. Jandinski JJ, Stashenko P, Feder LS, Leung CC, Peros WJ, Rynar JE, Deasy MJ. Localization of interleukin-1 beta in human periodontal tissue. J Periodontol 1991;62:36-43.
15. Stashenko P, Fujiyoshi P, Obernesser MS, Prostak L, Hafajee AD, Socransky SS. Levels of interleukin 1 beta in tissue from sites of active periodontal disease. J Clin Periodontal 1991;18:548-554.
16. Reindhardt RA, Masada MP, Johnson GK, Du Bois LM, Seymour GJ, Allison AC. IL-1 in gingival crevicular fluid following closed root planing and papillary flap debridement. J Clin Periodontol 1993;20:514-519.
17. Gamonal J, Acevedo A, Bascones A, Jorge O, Silva A. Levels of Interleukin-1, beta,-8, and -10 and RANTES in gingival crevicular fluid and cell populations in adult periodontitis patients and effect of periodontal treatment. J Periodontol 2000;71:1535-1545.
18. Schlinder C. Cytokine signal transduction. Receptor 1995;5:51-62.
19. Hernichel-Gorbach E, Kornman KS, Holt SC, et al. Host responses in patients with generalized refractory periodontitis. J Periodontol 1994;65:8-16.
20. Shapira L, Soskolne WA, Sela MN, Offenbacher S, Barak V. The secretion of PGE2, IL-1 beta, IL-6 and TNF alpha by adherent mononuclear cells from early-onset periodontitis patients. J Periodontol 1994;65:139-146.
21. Meisel P, Siegemund A, Grimm R, et al. The interleukin-1 polymorphism, smoking, and the risk of periodontal disease in the population-based SHIP study. J Dent Res 2003;82:189-193.
22. Stashenko P, Dewhirst FE, Peros WJ, Kent RL, Apo JM. Synergistic interactions between interleukin 1, tumor necrosis factor and lymphotoxin in bone resorption. J Immunol 1987;138:1484-1488.
23. Li YP, Stashenko P. Proinflammatory cytokines tumor necrosis factor-alpha and IL-6, but not IL-1, down-regulate the osteocalcin gene promoter. J Immunol 1992;148:788-794.
24. Foster S, McCormick LM, Ntolosi BA, Campbell D. Production of TNF alpha by LPS-stimulated murine rat and human blood and its pharmacological modulation. Agents Actions 1999;38(spec no):C77-C79.
25. Marcus AJ, Hajjar DP. Vascular transcellular signaling. J Lipid Res 1993;34:2017-2031.
26. Beck JD, Garcia R, Heiss G, Vokonas PS, Offenbacher S. Periodontal disease and cardiovascular disease. J Periodontol 1996;67:1123-1137.
27. De Nardin E. The role of inflammatory and immunological mediators in periodontitis and cardiovascular disease. Ann Periodontol 2001;6:30-40.
28. Roberts FA, McCaffery KA, Michalek SM. Profile of cytokine mRNA expression in chronic adult periodontitis. J Dent Res 1997;76:1833-1839.
29. Kesavalu L, Chandrasekar B, Ebersole JL. In vivo induction of proinflammatory cytokines in mouse tissue by Porphyromonas gingivalis and Actinobacillus actinomycetemcomitans. Oral Microbiol Immunol 2002;17:177-180.
30. Domeij H, Yucel-Lindberg T, Modeer T. Signal pathways involved in the production of MMP-1 and MMP-3 in human gingival fibroblasts. Eur J Oral Sci 2002;110:302-306.
31. DeCarlo AA Jr, Windsor LJ, Bodden MK, Harber GJ, Birkedal-Hansen B, Birkedal-Hansen H. Activation and novel processing of matrix metalloproteinases by a thiol-proteinase from the oral anaerobe Porphyromonas gingivalis. J Dent Res 1997;76:1260-1270.
32. Bickel M. The role of interleukin-8 in inflammation and mechanisms of regulation. J Periodontol 1993;64:456-460.
33. Gamonal J, Acevedo A, Bascones A, Jorge O, Silva A. Characterization of cellular infiltrate, detection of chemokine receptor CCR5 and interleukin-8 and RANTES chemokines in adult periodontitis. J Periodontal Res 2001;36:194-203.
34. Huang GT, Haake SK, Park N. Gingival epithelial cells increase interleukin-8 secretion in response to Actinobacillus actinomycetemcomitans challenge. J Periodontol 1998;69:1105-1110.
35. Okada H, Murakami S. Cytokine expression in periodontal health and disease. Crit Rev Oral Biol Med 1998;9:248-266.
36. Ohguchi Y, Ishihara Y, Ohguchi M, et al. Capsular polysaccharide from Actinobacillus actinomycetemcomitans inhibits IL-6 and IL-8 production in human gingival fibroblast. J Periodontal Res 2003;38:191-197.
37. Ebersole JL, Taubman MA. The protective nature of host responses in periodontal diseases. Periodontol 2000 1994;5:112-141.
38. Takeichi O, Haber J, Kawai T, Smith DJ, Moro I, Taubman MA. Cytokine profiles of T-lymphocytes from gingival tissues with pathological pocketing. J Dent Res 2000;79:1548-1555.
39. Yamamoto M, Kawabata K, Fujihashi K, et al. Absence of exogenous interleukin-4-induced apoptosis of gingival macrophages may contribute to chronic inflammation in periodontal diseases. Am J Pathol 1996;148:331-339.
40. Fujihashi K, Kono Y, Beagley KW, et al. Cytokines and periodontal disease: Immunopathological role of interleukins for B cell responses in chronic inflamed gingival tissues. J Periodontol 1993;64(suppl): 400-406.
41. Fujihashi K, Beagley KW, Kono Y, et al. Gingival mononuclear cells from chronic inflammatory periodontal tissues produce interleukin (IL)-5 and IL-6 but not IL-2 and IL-4. Am J Pathol 1993;142:1239-1250.
42. Geivelis M, Turner DW, Pederson ED, Laamberts BL. Measurements of interleukin-6 in gingival crevicular fluid from adults with destructive periodontal disease. J Periodontol 1993;64:980-983.
43. Yamazaki K, Nakajima T, Gemmell E, Polak B, Seymour GJ, Hara K. IL-4 and IL-6-producing cells in human periodontal disease tissue. J Oral Pathol Med 1994;23:347-353.
44. Dongari-Bagtzoglou AI, Ebersole JL. Increased presence of interleukin-6 (IL-6) and IL-8 secreting fibroblast subpopulations in adult periodontitis. J Periodontol 1998;69:899-910.
45. Reinhardt RA, Masada MP, Kaldahl WB, et al. Gingival fluid IL-1 and IL-6 levels in refractory periodontitis. J Clin Periodontol 1993;20:225-231.
46. Reinhardt RA, Masada MP, Payne JB, Allison AC, DuBois LM. Gingival crevicular fluid IL-1 beta and IL-6 levels in menopause. J Clin Periodontol 1994;21:22-25.
47. Offenbacher S, Heaseman PA, Collins JG. Modulation of host PGE2 secretion as a determinant of periodontal disease expression. J Periodontol 1993;64:432-444.
48. Howell TH, Williams RC. NSAIDs as inhibitors of periodontal disease progression. Crit Rev Oral Biol Med 1993;4:177-196.
49. Offenbacher S, Odle BM, Van Dyke TE. The use of crevicular fluid prostaglandin E2 levels as a predictor of periodontal attachment loss. J Periodontal Res 1986;21:101-112.
50. Nakashima K, Roerich N, Cimasoni G. Ostecalcin, prostaglandin E2 and alkaline phosphatase in gingival crevicular fluid: their relations to periodontal status. J Clin Periodontol 1994;21:327-333.
51. Salvi GE, Collins JG, Yalda B, Arnold RR, Lang NP, Offenbacher S. Monocytic TNF alpha secretion patterns in IDDM patients with periodontal diseases. J Clin Periodontol 1997;24:8-16.
52. Salvi GE, Collins JG, Yalda B, et al. Inflammatory mediator response as a risk marker for periodontal diseases in IDDM patients. J Periodontol 1997;68:127-135.
53. Valtonen W. Infection as a risk factor for infarction and atherosclerosis. Ann Med 1991;23:539-543.
54. Heasman PA. The role of NSAIDs in the management of periodontal disease. J Dent Res 1988;16:247-257.
55. Skaleric U, Kramar B, Petelin M, Pavlica Z Wahl SM. Changes in TGF-beta 1 levels in gingival crevicular fluid and serum associated with periodontal inflammation in humans and dogs. Eur J Oral Sci 1997;105:136-142.
56. Stashenko P, Obernesser MS, Dewhirst FE. Effect of immune cytokines on bone. Immunol Invest 1989;18:239-249.
57. Steinsvoll S, Halstensen TS, Schenck K. Extensive expression of TGF-beta1 in chronically-inflamed periodontal tissue. J Clin Periodontol 1999;26:366-373.
58. Olerud JE, Odland GF, Burgess EM, Wyss CR, Fisher LD, Matsen FA 3rd. A model for the study of wounds in normal elderly adults and patients with peripheral vascular disease or diabetes mellitus. J Surg Res 1995;59:349-360.